| 1 | [SID56323111] | Active | AC50 | 2.4 | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity [AID624132, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | AC50 | 2.4 [uM] | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624132 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID56323111] | Active | AC50 | 6.89 | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity [AID624133, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | AC50 | 6.89 [uM] | | BioAssay | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624133 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID56323111] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID56323111] | Active | Potency | 12.5893 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 5 | [SID56323111] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID56323111] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 7 | [SID56323111] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 8 | [SID56323111] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 9 | [SID56323111] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 10 | [SID56323111] | Active | AC50 | 56.7 | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity [AID624134, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | AC50 | 56.7 [uM] | | BioAssay | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624134 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID56323111] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID56323111] | Active | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56323111] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 14 | [SID56323111] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 15 | [SID56323111] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 16 | [SID56323111] | Active | | | Confirmation assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] [AID651638, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Confirmation assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] | | AID | 651638 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 17 | [SID56323111] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 18 | [SID56323111] | Active | | | Counter screen assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] in non-induced KCNK3 cells [AID651747, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Counter screen assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] in non-induced KCNK3 cells | | AID | 651747 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID56323111] | Active | | | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels [AID652147, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 652147 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID56323111] | Active | | | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels [AID588353, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 588353 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 21 | [SID56323111] | Active | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 22 | [SID56323111] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 23 | [SID56323111] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 24 | [SID56323111] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 25 | [SID56323111] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 26 | [SID56323111] | Inactive | Potency | 25.1189 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 27 | [SID56323111] | Inactive | Potency | 50.1187 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 28 | [SID56323111] | Inactive | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID56323111] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels [AID2648, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels | | AID | 2648 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 30 | [SID56323111] | Inactive | | | Validation for compounds that inhibit KCNQ1 potassium channels on automated electrophysiology assay [AID624120, Type: other] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Validation for compounds that inhibit KCNQ1 potassium channels on automated electrophysiology assay | | AID | 624120 | | BioAssay type | other | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 31 | [SID56323111] | Inactive | Potency | | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 32 | [SID56323111] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. [AID2029, Type: screening] | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. | | AID | 2029 | | BioAssay type | screening | | Target | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] | | PubMed | | | Data Table |  |
|
| 33 | [SID56323111] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 34 | [SID56323111] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 35 | [SID56323111] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 36 | [SID56323111] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 37 | [SID56323111] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 38 | [SID56323111] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 39 | [SID56323111] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 40 | [SID56323111] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 41 | [SID56323111] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 42 | [SID56323111] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 43 | [SID56323111] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 44 | [SID56323111] | Inactive | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 45 | [SID56323111] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 46 | [SID56323111] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 47 | [SID56323111] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 48 | [SID56323111] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 49 | [SID56323111] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 50 | [SID56323111] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56323111 | | CID | 24982336 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|